Hypertension is a chronic condition that requires proper management to prevent cardiovascular complications, and resistance exercise is a recommended strategy for its control. This study aimed to determine the acute effects of specific exercises, commonly used in resistance training programs, performed at two intensities (low and high) with equal volume, on blood pressure in individuals with pharmacologically controlled hypertension. A crossover clinical trial was conducted with 26 participants diagnosed with hypertension, each completing two resistance training sessions one low-intensity and one high-intensity including squats, rows, deadlifts, and bench presses. The order of exercise intensity for the first session was randomly assigned, and blood pressure was measured using an automated device before and immediately after each exercise. Comparisons between baseline and post-exercise values were analyzed, with a significance level set at 5%. The results showed that systolic blood pressure (SBP) increased during the squat, rows, and deadlift compared to baseline, with the deadlift producing the highest values. For diastolic blood pressure (DBP), no significant differences were observed from baseline, but the squat and deadlift elicited higher values than the rows and bench press. Additionally, high-intensity training resulted in lower DBP values compared to the low-intensity protocol. In conclusion, resistance exercise increases SBP regardless of intensity, with the squat and deadlift producing the most significant changes, while high-intensity training leads to lower DBP values than low-intensity protocols.

The authors have declared no competing interest.

NCT06370546

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Ethics committee of University Catholic of Maule approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

The data this article will be shared on reasonable request to the corresponding author.